■NEWS Survey Item Proposals for the Next Medical Fee Revision in FY2028 Approved – Subcommittee on Inpatient and Outpatient Medical Care, etc. – Japan Medical Journal Inc.

News Highlights

The proposed survey items for the next medical fee revision in FY2028 have been approved by the Subcommittee on Inpatient and Outpatient Medical Care, etc. This will concretize the direction of the revision, requiring medical institutions to develop management and business succession strategies at an early stage. In particular, utilizing tax schemes such as maintaining facility standards, distributing the burden of capital investment, and transitioning to specific medical corporations or social medical corporations may be emphasized to enjoy economies of scale.

Perspective from M&A Medical Editorial Department

The approval of the proposed survey items for the next revision is a “no time to wait” signal for medical institution managers. The FY2028 revision, in particular, is expected to involve more in-depth system design, such as rebuilding the medical care provision system after the COVID-19 pandemic and deepening the community-based integrated care system. For example, maintaining and strengthening facility standards will not only lead to additional remuneration but will also directly impact management stability and future M&A valuations. Grouping can create economies of scale, not only by distributing the burden of capital investment but also by generating a wide range of synergies, such as human resource development and joint ICT implementation. Furthermore, transitioning to specific medical corporations or social medical corporations can be an effective option for pursuing highly public-interest business development while receiving tax benefits. These strategies should not be considered as single-year measures but as urgent issues to be considered in conjunction with long-term business succession plans.

Points Raised by This News

• The approval of the proposed survey items for the FY2028 revision will have a concrete impact on the management and succession strategies of medical institutions.
• The pursuit of economies of scale through grouping may accelerate to maintain facility standards and distribute the burden of capital investment.
• Utilizing tax schemes, including transitioning to specific medical corporations and social medical corporations, can be key to stabilizing management.
• Early development of medium- to long-term management and succession plans, looking ahead to the next revision, will be essential for maintaining competitiveness.

Practical Questions Arising from This News

• What are the particularly noteworthy points in the proposed survey items this time?
• What M&A strategies can be considered to maintain and strengthen our institution’s facility standards?
• What are the specific advantages and disadvantages of considering a transition to a social medical corporation?

If You Feel “Should I Consult Too?”

Now that the proposed survey items for the FY2028 medical fee revision have been approved, it is a good opportunity to re-examine your institution’s management strategy and succession issues. In particular, it is worth considering whether options such as M&A or changes in corporate form are effective from the perspectives of maintaining and strengthening facility standards, distributing the burden of capital investment, and utilizing tax incentives. Why not consider consulting with an expert to build a sustainable management foundation for the future?

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. We handle consultations with strict confidentiality. Free consultation here